Research Funded To Date

SYSTEMATIC FUNCTIONAL INTERROGATION OF THE GBM GENOME FOR CURATIVE COMBINATION THERAPY (project details).

PIs: Ronald A. DePinho, M.D.
Director, Belfer Institute for Applied Cancer Science
Dana-Farber Cancer Institute

Lynda Chin, M.D.
Professor of Dermatology
Harvard Medical School
Dana-Farber Cancer Institute

Award: $2,997,067 over three years


USING GENOMIC SIGNATURES TO PREDICT COMBINATION THERAPY IN GBM (project details).

PIs: John H. Sampson, M.D., Ph.D., M.H.Sc.
Associate Professor of Surgery
Associate Deputy Director
Preston Robert Tisch Brain Tumor Center at Duke

Joseph R. Nevins, Ph.D.
Barbara Levine Professor of Cancer Genomics
Director Center for Applied Genomics & Technology
Duke Institute for Genome Sciences & Policy

Award: $2,452,367 over three years


18F PPRGD2 PET/CT, 18F FDG PET/CT AND MRI EVALUATION OF RESPONSE TO ANTI-ANGIOGENESIS THERAPY IN RECURRENT GLIOBLASTOMA MULTIFORME (project details).

PIs: Sanjiv Sam Gambhir, M.D., Ph.D.
Head of Radiology and Nuclear Medicine Program
Stanford University

Andrei H. Iagaru, M.D., F.A.C.N.M.
Associate Professor of Radiology
Co-Chief, Nuclear Medicine
Co-Director, Division of Nuclear Medicine and Molecular Imaging
Director, PET-MRI Research Program
Nuclear Medicine Residency Program
Stanford University Medical Center

Award: $1,479,171 over three years


IVY FOUNDATION EARLY PHASE CLINICAL TRIALS CONSORTIUM (project details).

PI:  Michael D. Prados, M.D.
Charles B. Wilson Professor of Neurosurgergery
Professor of Pediatrics (Neuro-Oncology)
Program Leader, Neurological Oncology Program, UCSF Helen Diller Cancer Center
Project Leader, Ivy Foundation Early Phase Clinical Trials Consortium
Project Leader, Pacific Pediatric Neuro-Oncology Consortium
University of California San Francisco (UCSF)

Award: $7,319,541 over nine years


THE IVY GBM ATLAS PROJECT: ANATOMIC GENE EXPRESSION ATLAS OF HUMAN GLIOBLASTOMA (project details).

PIs: Ralph B. Puchalski, Ph.D.
Research Alliance Manager
Allen Institute for Brain Science

Greg Foltz, M.D.
Director, Center for Advanced Brain Tumor Treatment
Swedish Neuroscience Institute

Award: $2,289,794 over four years